Manne Bhanu Kanth, Bhatlekar Seema, Middleton Elizabeth A, Weyrich Andrew S, Borst Oliver, Rondina Matthew T
Department of Internal Medicine and The Molecular Medicine Program, University of Utah, Salt Lake City, UT, USA.
Department of Pathology, University of Utah, Salt Lake City, UT, USA.
J Thromb Haemost. 2020 May;18(5):1183-1196. doi: 10.1111/jth.14748. Epub 2020 Mar 5.
Regulated protein synthesis is essential for megakaryocyte (MK) and platelet functions, including platelet production and activation. PDK1 (phosphoinositide-dependent kinase 1) regulates platelet functional responses and has been associated with circulating platelet counts. Whether PDK1 also directly regulates protein synthetic responses in MKs and platelets, and platelet production by MKs, remains unknown.
To determine if PDK1 regulates protein synthesis in MKs and platelets.
Pharmacologic PDK1 inhibitors (BX-795) and mice where PDK1 was selectively ablated in MKs and platelets (PDK1 ) were used. PDK1 signaling in MKs and platelets (human and murine) were assessed by immunoblots. Activation-dependent translation initiation and protein synthesis in MKs and platelets was assessed by probing for dissociation of eIF4E from 4EBP1, and using m7-GTP pulldowns and S methionine incorporation assays. Proplatelet formation by MKs, synthesis of Bcl-3 and MARCKs protein, and clot retraction were employed for functional assays.
Inhibiting or ablating PDK1 in MKs and platelets abolished the phosphorylation of 4EBP1 and eIF4E by preventing activation of the PI3K and MAPK pathways. Inhibiting PDK1 also prevented dissociation of eIF4E from 4EBP1, decreased binding of eIF4E to m7GTP (required for translation initiation), and significantly reduced de novo protein synthesis. Inhibiting PDK1 reduced proplatelet formation by human MKs and blocked MARCKs protein synthesis. In both human and murine platelets, PDK1 controlled Bcl-3 synthesis. Inhibition of PDK1 led to complete failure of clot retraction in vitro.
PDK1 is a previously unidentified translational regulator in MKs and platelets, controlling protein synthetic responses, proplatelet formation, and clot retraction.
受调控的蛋白质合成对于巨核细胞(MK)和血小板功能至关重要,包括血小板生成和激活。磷酸肌醇依赖性激酶1(PDK1)调节血小板功能反应,并与循环血小板计数有关。PDK1是否也直接调节MK和血小板中的蛋白质合成反应以及MK产生血小板的过程仍不清楚。
确定PDK1是否调节MK和血小板中的蛋白质合成。
使用药理学PDK1抑制剂(BX - 795)以及在MK和血小板中选择性敲除PDK1的小鼠(PDK1Δ)。通过免疫印迹评估MK和血小板(人和小鼠)中的PDK1信号传导。通过检测eIF4E与4EBP1的解离,并使用m7 - GTP下拉实验和S-甲硫氨酸掺入实验,评估MK和血小板中激活依赖性的翻译起始和蛋白质合成。采用MK的前血小板形成、Bcl - 3和MARCKs蛋白的合成以及凝块回缩进行功能实验。
在MK和血小板中抑制或敲除PDK1可通过阻止PI3K和MAPK途径的激活,消除4EBP1和eIF4E的磷酸化。抑制PDK1还可阻止eIF4E与4EBP1的解离,降低eIF4E与m7GTP(翻译起始所需)的结合,并显著减少从头蛋白质合成。抑制PDK1可减少人MK的前血小板形成并阻断MARCKs蛋白合成。在人和小鼠血小板中,PDK1都控制Bcl - 3的合成。抑制PDK1导致体外凝块回缩完全失败。
PDK1是MK和血小板中先前未被鉴定的翻译调节因子,控制蛋白质合成反应、前血小板形成和凝块回缩。